"Drug Industry" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
That segment of commercial enterprise devoted to the design, development, and manufacture of chemical products for use in the diagnosis and treatment of disease, disability, or other dysfunction, or to improve function.
| Descriptor ID |
D004345
|
| MeSH Number(s) |
J01.576.655.750
|
| Concept/Terms |
Drug Industry- Drug Industry
- Industry, Pharmaceutic
- Industries, Pharmaceutic
- Pharmaceutic Industries
- Pharmaceutic Industry
- Industry, Drug
- Drug Industries
- Industries, Drug
- Industry, Pharmaceutical
- Industries, Pharmaceutical
- Pharmaceutical Industries
- Pharmaceutical Industry
|
Below are MeSH descriptors whose meaning is more general than "Drug Industry".
Below are MeSH descriptors whose meaning is more specific than "Drug Industry".
This graph shows the total number of publications written about "Drug Industry" by people in this website by year, and whether "Drug Industry" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Industry" by people in Profiles.
-
Direct-to-consumer offers for free and discounted medications on the internet: a content analysis of "e-samples". Arch Intern Med. 2009 Nov 23; 169(21):2024-30.
-
Reducing the prescribing of heavily marketed medications: a randomized controlled trial. J Gen Intern Med. 2009 Aug; 24(8):897-903.
-
Asthma quality-of-care measures using administrative data: relationships to subsequent exacerbations in multiple databases. Ann Allergy Asthma Immunol. 2008 Sep; 101(3):235-9.
-
Direct-to-consumer advertising of COX-2 inhibitors: effect on appropriateness of prescribing. Med Care Res Rev. 2005 Oct; 62(5):544-59.
-
Inconsistency in DTCA practices by manufacturers: is it time to standardize print summaries? Value Health. 2004 Mar-Apr; 7(2):216-7.
-
Commercial development considerations for biotechnology-derived therapeutics. Cardiovasc Toxicol. 2003; 3(1):5-12.
-
A physician survey of the effect of drug sample availability on physicians' behavior. J Gen Intern Med. 2000 Jul; 15(7):478-83.
-
Market structure and advertising in the U.S. pharmaceutical industry: some implications for public policy. Med Care. 1978 Feb; 16(2):90-109.